Seer (SEER) Change in Receivables (2020 - 2026)
Seer (SEER) recorded quarterly Change in Receivables of -$1.7 million in Q1 2026, down 313.33% quarter-over-quarter from $795000.0 in Q4 2025, and down 93.83% on a YoY basis from -$27.5 million in Q1 2025.
Seer (SEER) Change in Receivables (2020 - 2026) Analysis & Trends
Seer's Change in Receivables history runs 7 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 93.83% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$1.1 million (down 37.94% YoY), while the FY2025 annual figure was -$277000.0, up 43.12% from the prior year.
- Change in Receivables was -$1.7 million for Q1 2026 at Seer, down from $795000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.4 million in Q3 2023 to a low of -$1.7 million in Q1 2026.
- Historically, Change in Receivables has averaged $6588.2 across 5 years, with a median of $165000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables sank 443.03% in 2024, then soared 459.73% in 2025.
- A 5-year view of Change in Receivables shows it stood at $640000.0 in 2022, then slumped by 260.94% to -$1.0 million in 2023, then surged by 78.54% to -$221000.0 in 2024, then jumped by 459.73% to $795000.0 in 2025, then tumbled by 313.33% to -$1.7 million in 2026.
- The last three Change in Receivables figures came in at -$1.7 million (Q1 2026), $795000.0 (Q4 2025), and -$557000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 795,000.00 |
| Dec 31, 2025 | 795,000.00 |
| Sep 30, 2025 | -557,000.00 |
| Sep 30, 2025 | -557,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Mar 31, 2025 | -875,000.00 |
| Mar 31, 2025 | -875,000.00 |
| Dec 31, 2024 | -221,000.00 |
| Dec 31, 2024 | -221,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Jun 30, 2024 | -449,000.00 |
| Jun 30, 2024 | -449,000.00 |
| Mar 31, 2024 | -566,000.00 |
| Mar 31, 2024 | -566,000.00 |
| Dec 31, 2023 | -1.03 Mn |
| Dec 31, 2023 | -1.03 Mn |